english.prescrire.org > Prescrire International > N°150 - June 2014

n°150

June 2014

Issue Contents
Editorial

Free  Choosing to avoid poor-quality healthcare

p.144
Better care can be a matter of knowing what not to prescribe

New Products


Delta-9-tetrahydrocannabinol + cannabidiol (New Drug)

p.145-148
A reasonable option for some patients with multiple sclerosis

INN common stem: nal-

p.148

Insulin degludec (New Drug)

p.149
Uncertainty over cardiovascular harms

Nalmefene (New Drug)

p.150-152
Alcohol dependence: no advance

Adverse Effects


Medication-induced violence towards others

p.153-155
Problems encountered in the pharmacovigilance of violence and aggression

Alzheimer's disease in France: too many patients exposed to drug interactions involving cholinesterase inhibitors

p.156
A Prescrire study

Capecitabine: toxic epidermal necrolysis and Stevens-Johnson syndrome

p.157
Bullous rash

Mefloquine: persistent vestibular disorders

p.157
Recognizing the problem early is key

Contraceptive implants: pregnancies and problems with removal

p.157
A pharmacovigilance survey

Reviews


Antibiotic therapy for acute appendicitis in adults

p.158-160
Fewer immediate complications than with surgery, but more subsequent failures

Outlook


Free  Towards better patient care: drugs to avoid in 2014

p.161-165
68 drugs more harmful than helpful

Free  Facts and figures

p.166-167
Prescrire's annual financial report

Masthead


Free  Masthead

p.142

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe